Advisory Board Agreement between a patient advocate and a pharmaceutical companyAdvisory Board Agreement • August 21st, 2019
Contract Type FiledAugust 21st, 2019This is a reference agreement, specific for advisory board engagements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”, For the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp